Neurology

• 

  Publication Venue For

  • Racial and Ethnic Differences in Health-Related Quality of Life for Individuals With Parkinson Disease Across Centers of Excellence..  100:e2170-e2181. 2023
  • Association Between Neighborhood Socioeconomic Status and 30-Day Mortality and Readmission for Patients With Common Neurologic Conditions..  100:e1776-e1786. 2023
  • Child Neurology: Infantile Biotin Thiamine Responsive Basal Ganglia Disease: Case Report and Brief Review..  100:836-839. 2023
  • Association Between Statin Use and Intracerebral Hemorrhage Location: A Nested Case-Control Registry Study..  100:e1048-e1061. 2023
  • The ALIGN Framework: A Parent-Informed Approach to Prognostic Communication for Infants With Neurologic Conditions..  100:e800-e807. 2023
  • Neurodevelopmental and Epilepsy Phenotypes in Individuals With Missense Variants in the Voltage-Sensing and Pore Domains of KCNH5..  100:e603-e615. 2023
  • Clinical Features, Neuropathology, and Surgical Outcome in Patients With Refractory Epilepsy and Brain Somatic Variants in the SLC35A2 Gene..  100:e528-e542. 2023
  • Predictors of Recurrent Venous Thrombosis After Cerebral Venous Thrombosis: Analysis of the ACTION-CVT Study..  99:e2368-e2377. 2022
  • Clinical Reasoning: A 36-Year-Old Man With Asymmetric Muscle Weakness. 2022
  • Association Between Lysine Reduction Therapies and Cognitive Outcomes in Patients With Pyridoxine-Dependent Epilepsy..  99:e2627-e2636. 2022
  • Who to Enroll in Parkinson Disease Prevention Trials? The Case for Genetically At-Risk Cohorts..  99:10-18. 2022
  • Teaching NeuroImage: Non-24-Hour Sleep-Wake Rhythm Disorder..  98:945-946. 2022
  • Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease..  99:e536-e548. 2022
  • Association of Long-term Statin Use With the Risk of Intracerebral Hemorrhage: A Danish Nationwide Case-Control Study. 2022
  • Prolonged Cardiac Monitoring and Stroke Recurrence: A Meta-analysis..  98:e1942-e1952. 2022
  • Race-Ethnic Disparities in Rates of Declination of Thrombolysis for Stroke..  98:e1596-e1604. 2022
  • Stroke Prevention in Symptomatic Large Artery Intracranial Atherosclerosis Practice Advisory: Report of the AAN Guideline Subcommittee..  98:486-498. 2022
  • Antiseizure Medication Withdrawal in Seizure-Free Patients: Practice Advisory Update Summary: Report of the AAN Guideline Subcommittee..  97:1072-1081. 2021
  • Clinical Reasoning: A 55-Year-Old Man With Odd Behavior and Abnormal Movements..  97:1090-1093. 2021
  • Teaching Video NeuroImage: Hereditary Hyperekplexia Mimicking Tonic Seizures in an Infant..  97:e2248-e2249. 2021
  • Effects of Fragmentation and the Case for Greater Cohesion in Neurologic Care Delivery. 2021
  • Decisions With Patients and Families Regarding Aducanumab in Alzheimer Disease, With Recommendations for Consent: AAN Position Statement. 2021
  • Contemporary Neuroscience Core Curriculum for Medical Schools..  97:675-684. 2021
  • Seizure Control in Neonates Undergoing Screening vs Confirmatory EEG Monitoring..  97:e587-e596. 2021
  • Clinical Reasoning: A 64-Year-Old Man With Multiple Cranial Neuropathies..  97:e215-e221. 2021
  • Author Response: Education Research: The Medical Student Perspective on Challenging Conversations..  96:869. 2021
  • Trajectory-Based Classification of Recovery in Sensorimotor Complete Traumatic Cervical Spinal Cord Injury. 2021
  • Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis: Long-term Extension of RESILIENT..  96:e1595-e1607. 2021
  • Clinical Practice Guidelines by the Infectious Diseases Society of America, American Academy of Neurology, and American College of Rheumatology: 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease..  96:262-273. 2021
  • Efficacy and Safety of Rozanolixizumab in Moderate to Severe Generalized Myasthenia Gravis: A Phase 2 Randomized Control Trial..  96:e853-e865. 2021
  • Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension..  96:e610-e618. 2021
  • International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update..  96:114-122. 2021
  • Developing the Neurology Diversity Officer: A Roadmap for Academic Neurology Departments. 2021
  • Identification of a pathogenic intronic KIF5A mutation in an ALS-FTD kindred..  95:1015-1018. 2020
  • Cardiac phenotype in ATP1A3-related syndromes: A multicenter cohort study..  95:e2866-e2879. 2020
  • The impact of delirium on withdrawal of life-sustaining treatment after intracerebral hemorrhage..  95:e2727-e2735. 2020
  • First-line medication dosing in pediatric refractory status epilepticus..  95:e2683-e2696. 2020
  • Sex, race, and risk of dementia diagnosis after traumatic brain injury among older veterans..  95:e1768-e1775. 2020
  • Reader response: The dimension of preventable stroke in a large representative patient cohort..  95:557-558. 2020
  • Reader response: Optimizing in-hospital triage for large vessel occlusion using a novel clinical scale (GAI2AA)..  95:460. 2020
  • Association of guideline publication and delays to treatment in pediatric status epilepticus..  95:e1222-e1235. 2020
  • Minimal manifestation status and prednisone withdrawal in the MGTX trial..  95:e755-e766. 2020
  • Novel approaches to quantify CNS involvement in children with Pompe disease..  95:e718-e732. 2020
  • Education Research: The medical student perspective on challenging conversations..  95:226-230. 2020
  • Preserving stroke care during the COVID-19 pandemic: Potential issues and solutions..  95:124-133. 2020
  • Serum triglycerides in Alzheimer disease: Relation to neuroimaging and CSF biomarkers..  94:e2088-e2098. 2020
  • Funds flow in academic neurology: A potential path to financial success..  94:785-791. 2020
  • Defining research priorities in dystonia..  94:526-537. 2020
  • Practice guideline: Treatment for insomnia and disrupted sleep behavior in children and adolescents with autism spectrum disorder: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology..  94:392-404. 2020
  • Child Neurology: A young child with an undiagnosed case of dystonia responsive to l-dopa..  94:326-328. 2020
  • Reader response: Patient-reported outcomes across cerebrovascular event types: More similar than different..  93:905. 2019
  • The epileptology of alternating hemiplegia of childhood..  93:e1248-e1259. 2019
  • Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function..  93:e1312-e1323. 2019
  • Hospital distance, socioeconomic status, and timely treatment of ischemic stroke..  93:e747-e757. 2019
  • Reader response: A sleep medicine medical school curriculum: Time for us to wake up..  93:134. 2019
  • Thrombolysis in young adults with acute ischemic stroke: Quicker may be better..  92:1129-1130. 2019
  • Thrombolysis in young adults with stroke: Findings from Get With The Guidelines-Stroke..  92:e2784-e2792. 2019
  • Efgartigimod: A novel antibody depletion therapy in myasthenia gravis..  92:1079-1080. 2019
  • Haptoglobin genotype and aneurysmal subarachnoid hemorrhage: Individual patient data analysis..  92:e2150-e2164. 2019
  • Reader response: Association of statin use with spontaneous intracerebral hemorrhage: A cohort study..  92:821-822. 2019
  • Meeting Medicare requirements for transitional care: Do stroke care and policy align?.  92:427-434. 2019
  • Serum magnesium and calcium levels in relation to ischemic stroke: Mendelian randomization study..  92:e944-e950. 2019
  • Type 2 diabetes mellitus, brain atrophy, and cognitive decline..  92:e823-e830. 2019
  • Neurologic and neuroscience education: Mitigating neurophobia to mentor health care providers..  92:174-179. 2019
  • Genetic and lifestyle risk factors for MRI-defined brain infarcts in a population-based setting..  92:e486-e503. 2019
  • Lifestyle and neurocognition in older adults with cognitive impairments: A randomized trial..  92:e212-e223. 2019
  • Emerging Subspecialties in Neurology: Sports neurology training and certification: An overview in 2018..  91:980-982. 2018
  • Outcomes after carotid endarterectomy among elderly dual Medicare-Medicaid-eligible patients..  91:e1553-e1558. 2018
  • A dozen years of evolution of neurology clerkships in the United States: Looking up..  91:e1440-e1447. 2018
  • Author response: Education Research: Difficult conversations in neurology: Lessons learned from medical students..  91:636. 2018
  • Reader response: Residency training: The review committee for neurology: Revisions to the common program requirements..  91:429. 2018
  • Neuropalliative care: Priorities to move the field forward..  91:217-226. 2018
  • Independent home use of a brain-computer interface by people with amyotrophic lateral sclerosis..  91:e258-e267. 2018
  • Autoimmune pancerebellitis associated with pembrolizumab therapy..  91:91-93. 2018
  • Geometric morphometrics reveal altered corpus callosum shape in pyridoxine-dependent epilepsy..  91:e78-e86. 2018
  • Hypertension and intracerebral hemorrhage recurrence among white, black, and Hispanic individuals..  91:e37-e44. 2018
  • Survival and independence after intracerebral hemorrhage: Trends and opportunities..  90:1043-1044. 2018
  • Validation of a simple disease-specific, quality-of-life measure for diabetic polyneuropathy: CAPPRI..  90:e2034-e2041. 2018
  • Factors associated with treatment delays in pediatric refractory convulsive status epilepticus..  90:e1692-e1701. 2018
  • Randomized study of adjunctive belimumab in participants with generalized myasthenia gravis..  90:e1425-e1434. 2018
  • A multinational study on motor function in early-onset FSHD..  90:e1333-e1338. 2018
  • Silent cerebral infarct definitions and full-scale IQ loss in children with sickle cell anemia..  90:e239-e246. 2018
  • Education Research: Difficult conversations in neurology: Lessons learned from medical students..  90:93-97. 2018
  • Association of metabolic syndrome and change in Unified Parkinson's Disease Rating Scale scores..  89:1789-1794. 2017
  • Author response: Ischemic Lesions, blood pressure dysregulation, and poor outcomes in intracerebral hemorrhage..  89:1755-1756. 2017
  • Teaching NeuroImages: Artery of Percheron thrombosis causing selective downgaze palsy..  89:e197-e198. 2017
  • Assessment of the interaction of age and sex on 90-day outcome after intracerebral hemorrhage..  89:1011-1019. 2017
  • Rituximab as treatment for anti-MuSK myasthenia gravis: Multicenter blinded prospective review..  89:1069-1077. 2017
  • Cardiovascular health in young adulthood and structural brain MRI in midlife: The CARDIA study..  89:680-686. 2017
  • Clinical Reasoning: Two see or not two see-Is it really double vision?.  89:e56-e60. 2017
  • Aggressiveness of care following intracerebral hemorrhage in women and men..  89:349-354. 2017
  • Author response: Transient smartphone blindness: Relevance to misdiagnosis in neurologic practice..  89:306-307. 2017
  • Author response: Influence of sodium consumption and associated knowledge on poststroke hypertension in Uganda..  88:1103. 2017
  • Ischemic lesions, blood pressure dysregulation, and poor outcomes in intracerebral hemorrhage..  88:782-788. 2017
  • Transient smartphone blindness: Relevance to misdiagnosis in neurologic practice..  88:809-810. 2017
  • TOMM40'523 variant and cognitive decline in older persons with APOE ε3/3 genotype..  88:661-668. 2017
  • Author response: International consensus guidance for management of myasthenia gravis: Executive summary..  88:505-506. 2017
  • Long-term cortisol measures predict Alzheimer disease risk..  88:371-378. 2017
  • Refractory status epilepticus in children with and without prior epilepsy or status epilepticus..  88:386-394. 2017
  • A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease..  88:152-159. 2017
  • Large-scale identification of patients with cerebral aneurysms using natural language processing..  88:164-168. 2017
  • Right Brain: Breaking bad news: Communication education for neurology trainees..  87:e285-e287. 2016
  • IV tPA for acute ischemic stroke: Times are changing..  87:2178-2179. 2016
  • Choroid plexus hyperplasia: A possible cause of hydrocephalus in adults..  87:2058-2060. 2016
  • Cortical cerebral microinfarcts on 3T MRI: A novel marker of cerebrovascular disease..  87:1583-1590. 2016
  • Influence of sodium consumption and associated knowledge on poststroke hypertension in Uganda..  87:1198-1205. 2016
  • Racial-ethnic disparities in acute blood pressure after intracerebral hemorrhage..  87:786-791. 2016
  • Nonstenotic carotid plaques: Stroke causation or guilt by association?.  87:650-651. 2016
  • Statin pretreatment is associated with better outcomes in large artery atherosclerotic stroke..  87:746. 2016
  • International consensus guidance for management of myasthenia gravis: Executive summary..  87:419-425. 2016
  • Sex differences exist after intracerebral hemorrhage but may not affect outcome..  87:244. 2016
  • A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis..  87:57-64. 2016
  • Failures to discuss and document preferences: Preventable medical errors in stroke care..  86:2032-2033. 2016
  • Statins and poststroke intracerebral hemorrhage: Concern but increasing reassurance..  86:1570-1571. 2016
  • Novel susceptibility gene for nonfamilial hypokalemic periodic paralysis..  86:1190-1198. 2016
  • Comment: Is 3,4-DAP a new option in treating MuSK MG?.  86:1071. 2016
  • Urinary LRRK2 phosphorylation predicts parkinsonian phenotypes in G2019S LRRK2 carriers..  86:994-999. 2016
  • Incontinence and gait disturbance after intraventricular extension of intracerebral hemorrhage..  86:905-911. 2016
  • Cognitive-behavioral screening reveals prevalent impairment in a large multicenter ALS cohort..  86:813-820. 2016
  • How common are ALS plateaus and reversals?.  86:808-812. 2016
  • Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis..  86:382-390. 2016
  • Clinician judgment vs formal scales for predicting intracerebral hemorrhage outcomes..  86:126-133. 2016
  • Genome-wide meta-analysis of cerebral white matter hyperintensities in patients with stroke..  86:146-153. 2016
  • Comment: Neurophysiologic intraoperative monitoring in "low-risk" spine surgeries..  85:2157. 2015
  • Fruit flies, bile acids, and Parkinson disease: a mitochondrial connection?.  85:838-839. 2015
  • SSADH deficiency in an adult: Venturing outside of the diagnostic box and inside of the registry..  85:842-843. 2015
  • The unruptured intracranial aneurysm treatment score: a multidisciplinary consensus..  85:881-889. 2015
  • Intragenic deletions of ALDH7A1 in pyridoxine-dependent epilepsy caused by Alu-Alu recombination..  85:756-762. 2015
  • Effect of clopidogrel with aspirin on functional outcome in TIA or minor stroke: CHANCE substudy..  85:573-579. 2015
  • Emerging subspecialties in neurology: neurorehabilitation..  85:e50-e52. 2015
  • Improving early clinical trial phase identification of promising therapeutics..  85:274-283. 2015
  • Screening with MRI for Accurate and Rapid Stroke Treatment: SMART..  84:2438-2444. 2015
  • Time from convulsive status epilepticus onset to anticonvulsant administration in children..  84:2304-2311. 2015
  • Teaching NeuroImages: Radiation-associated symptomatic carotid artery disease with ipsilateral radiodermatitis..  84:e31-e32. 2015
  • Factors associated with cognitive evaluations in the United States..  84:64-71. 2015
  • Declining stroke mortality in young adults: hope and concern..  83:2102-2103. 2014
  • Pearls & Oy-sters: polycythemia vera presenting with ischemic strokes in multiple arterial territories..  82:e168-e170. 2014
  • Plasma FGF23 and the risk of stroke: the Northern Manhattan Study (NOMAS)..  82:1700-1706. 2014
  • Pyridoxine or pyridoxal-5'-phosphate for neonatal epilepsy: the distinction just got murkier..  82:1392-1394. 2014
  • Lower stroke risk with lower blood pressure in hemodynamic cerebral ischemia..  82:1027-1032. 2014
  • Sex differences in quality of life after ischemic stroke..  82:922-931. 2014
  • Randomized Evaluation of Carotid Occlusion and Neurocognition (RECON) trial: main results..  82:744-751. 2014
  • Summary of evidence-based guideline: Periprocedural management of antithrombotic medications in patients with ischemic cerebrovascular disease: report of the Guideline Development Subcommittee of the American Academy of Neurology..  82:95. 2014
  • CSF biomarker changes precede symptom onset of mild cognitive impairment..  81:1753-1758. 2013
  • Ultrasound as the first choice for peripheral nerve imaging?.  81:1644. 2013
  • Ultrasound as the first choice for peripheral nerve imaging?.  81:1644-1645. 2013
  • Identification of a novel risk variant in the FUS gene in essential tremor..  81:541-544. 2013
  • JURaSSiC: accuracy of clinician vs risk score prediction of ischemic stroke outcomes..  81:448-455. 2013
  • Re: Stroke in sub-Saharan Africa: an urgent call for prevention..  81:403-404. 2013
  • Summary of evidence-based guideline: periprocedural management of antithrombotic medications in patients with ischemic cerebrovascular disease: report of the Guideline Development Subcommittee of the American Academy of Neurology..  80:2065-2069. 2013
  • Teaching neuroimages: vein of Galen aneurysm mimicking pineal mass in a young adult..  80:e240. 2013
  • Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients..  80:1698-1701. 2013
  • Ultrasound as the first choice for peripheral nerve imaging?.  80:1626-1627. 2013
  • SLC1A2 variant associated with essential tremor but not Parkinson disease in Chinese subjects..  80:1618-1619. 2013
  • From the bridges of Konigsberg to the fields of Alzheimer: connecting the dots..  80:1360-1362. 2013
  • Blurring of local and remote practice models threatens IOM's future..  80:1076-1077. 2013
  • Cognitive outcome of patients with classic infantile Pompe disease receiving enzyme therapy..  80:1173. 2013
  • Association between performance on Neurology In-Training and Certification Examinations..  80:206-209. 2013
  • Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning..  80:47-54. 2013
  • Emerging subspecialties in neurology: Clinical development..  80:e4-e7. 2013
  • Acute EEG findings in children with febrile status epilepticus: results of the FEBSTAT study..  79:2180-2186. 2012
  • Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study..  79:1846-1852. 2012
  • Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study..  79:1636-1644. 2012
  • MRI abnormalities following febrile status epilepticus in children: the FEBSTAT study..  79:871-877. 2012
  • Comment: Child neurology training--the adult neurology program director perspective..  79:819. 2012
  • Effect of insurance status on postacute care among working age stroke survivors..  78:1590-1595. 2012
  • Intracranial optic nerve enlargement in infantile Krabbe disease..  78:e126. 2012
  • Prevalence and comorbidity of nocturnal wandering in the U.S. adult general population..  78:1583-1589. 2012
  • A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease..  78:1229-1236. 2012
  • Cerebral hemodynamics and cognitive impairment: baseline data from the RECON trial..  78:250-255. 2012
  • Nicotine treatment of mild cognitive impairment: a 6-month double-blind pilot clinical trial..  78:91-101. 2012
  • Secondary preventive medication persistence and adherence 1 year after stroke..  77:1182-1190. 2011
  • Historical controls in ALS trials: a high seas rescue?.  77:936-937. 2011
  • Retinal microvascular changes and subsequent vascular events after ischemic stroke..  77:896-903. 2011
  • Outcomes after ischemic stroke for hospitals with and without Joint Commission-certified primary stroke centers..  76:1976-1982. 2011
  • Fractal dimension of the retinal vasculature and risk of stroke: a nested case-control study..  76:1766-1767. 2011
  • Emerging subspecialties in neurology: neurophysiologic intraoperative monitoring..  76:e73-e75. 2011
  • Pearls & Oy-sters: multiple ischemic strokes secondary to heparin-induced thrombocytopenia..  76:e48-e50. 2011
  • Default mode network connectivity in stable vs progressive mild cognitive impairment..  76:511-517. 2011
  • Myasthenic syndrome caused by plectinopathy..  76:327-336. 2011
  • Analysis of current multiple sclerosis registries..  76:S7-13. 2011
  • Registry studies of long-term multiple sclerosis outcomes: description of key registries..  76:S3-S6. 2011
  • Licorice-associated reversible cerebral vasoconstriction with PRES..  75:1939-1941. 2010
  • Spinal cord stimulation failed to relieve akinesia or restore locomotion in Parkinson disease..  75:1484. 2010
  • Trends in American Board of Psychiatry and Neurology specialties and neurologic subspecialties..  75:1110-1117. 2010
  • Teaching video NeuroImages: painful legs and moving toes syndrome..  75:e6. 2010
  • A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease..  74:2026. 2010
  • Occupational exposure to pesticides increases the risk of incident AD: the Cache County study..  74:1524-1530. 2010
  • The MG Composite: A valid and reliable outcome measure for myasthenia gravis..  74:1434-1440. 2010
  • The quest for the "Holy Grail" of ischemic stroke cytoprotection: Statins may not be the answer..  73:2058-2059. 2009
  • Acgme, test thyself!.  73:1811. 2009
  • Retinal microvascular abnormalities and cognitive decline: the ARIC 14-year follow-up study..  73:862-868. 2009
  • Influence of stroke subtype on quality of care in the Get With The Guidelines-Stroke Program..  73:709-716. 2009
  • Will submandibular TCD prevent stroke in children with sickle cell anemia?.  73:340-341. 2009
  • Lifespan influences on mid- to late-life cognitive function in a Chinese birth cohort..  73:186-194. 2009
  • Very Early Constraint-Induced Movement during Stroke Rehabilitation (VECTORS): A single-center RCT..  73:195-201. 2009
  • Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study..  72:1447. 2009
  • ACGME competencies in neurology: web-based objective simulated computerized clinical encounters..  72:893-898. 2009
  • Re: Epilepsy-associated bone mineral density loss should be prevented..  72:943. 2009
  • Education research: neurology continuity clinic. Improving the timing of the experience..  72:e43. 2009
  • Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack..  72:688-694. 2009
  • Alzheimer disease: what changes in the brain cause dementia?.  72:e21. 2009
  • Education research: neurology residency training in the new millennium..  72:e15-e20. 2009
  • Visual evoked potentials with CRT and LCD monitors: when newer is not better..  72:162-164. 2009
  • Novel congenital myopathy locus identified in Native American Indians at 12q13.13-14.1..  71:1764-1769. 2008
  • Invited article: The ABPN maintenance of certification program for neurologists: past, present, and future..  71:599-604. 2008
  • A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis..  71:394-399. 2008
  • An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis..  71:400-406. 2008
  • Cell-based interventions for neurologic conditions: ethical challenges for early human trials..  71:288-293. 2008
  • Phenomenology of prolonged febrile seizures: results of the FEBSTAT study..  71:170-176. 2008
  • Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study..  70:2364-2370. 2008
  • No advantage of A beta 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies..  70:2291-2298. 2008
  • Adjunctive lamotrigine for partial seizures in patients aged 1 to 24 months..  70:2099-2108. 2008
  • Associations of job demands and intelligence with cognitive performance among men in late life..  70:1803-1808. 2008
  • Differential survival with Alzheimer disease..  70:1158-1160. 2008
  • Response of infantile spasms to levetiracetam..  70:574-575. 2008
  • Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study..  70:2364-2370. 2008
  • Joint effect of stroke and APOE 4 on dementia risk: the Canadian Study of Health and Aging..  70:9-16. 2008
  • Vascular factors predict rate of progression in Alzheimer disease..  69:1850-1858. 2007
  • Independent predictors of stroke in patients with atrial fibrillation: a systematic review..  69:546-554. 2007
  • Visual function at baseline and 1 month in acute optic neuritis: predictors of visual outcome..  69:508-514. 2007
  • Does NSAID use modify cognitive trajectories in the elderly? The Cache County study..  69:275-282. 2007
  • Long-term patterns of weight changes during topiramate therapy: an observational study..  69:310-311. 2007
  • The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) trial..  68:2099-2106. 2007
  • Two randomized vitamin D trials in ambulatory patients on anticonvulsants: impact on bone..  68:1958-1959. 2007
  • Migraine and retinal microvascular abnormalities: the Atherosclerosis Risk in Communities Study..  68:1694-1700. 2007
  • Certification in neuromuscular medicine: a new neurologic subspecialty..  68:1153-1154. 2007
  • Genetic diagnosis in Lafora disease: genotype-phenotype correlations and diagnostic pitfalls..  68:996-1001. 2007
  • Neurofibromatosis type 2..  68:E14. 2007
  • Occurrence of amyotrophic lateral sclerosis among Gulf War veterans..  68:1083. 2007
  • Low LDL cholesterol, statins, and brain hemorrhage: should we worry?.  68:719-720. 2007
  • Genotype-phenotype study in an FSHD family with a proximal deletion encompassing p13E-11 and D4Z4..  68:578-582. 2007
  • Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers..  68:471. 2007
  • Symptomatic autoregulatory failure in acute ischemic stroke..  68:389-390. 2007
  • Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease..  68:99-109. 2007
  • A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease..  68:20-28. 2007
  • Two randomized vitamin D trials in ambulatory patients on anticonvulsants: impact on bone..  67:2005-2014. 2006
  • Vascular risk factors and cognitive decline among elderly male twins..  67:1586-1591. 2006
  • Effect of a clinical stroke on the risk of dementia in a prospective cohort..  67:1363-1369. 2006
  • Occupational characteristics and cognitive performance among elderly male twins..  67:1377-1382. 2006
  • Gray matter abnormalities in autism spectrum disorder revealed by T2 relaxation..  67:632-636. 2006
  • Conversion to dementia from mild cognitive disorder: the Cache County Study..  67:229-234. 2006
  • Peripheral neuropathy in Krabbe disease: effect of hematopoietic stem cell transplantation..  67:268-272. 2006
  • Peripheral neuropathy in Krabbe disease: electrodiagnostic findings..  67:263-267. 2006
  • Exploring the association of glyceraldehyde-3-phosphate dehydrogenase gene and Alzheimer disease..  67:64-68. 2006
  • MR DWI does not substitute for stroke severity scores in predicting stroke outcome..  66:1138-1139. 2006
  • Hanging leg syndrome: combined bilateral femoral and sciatic neuropathies..  66:1124-1125. 2006
  • Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis..  66:954-955. 2006
  • What does cerebral platelet activation mean in the setting of carotid stenosis?.  66:792-793. 2006
  • A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease..  66:664-671. 2006
  • Primum non nocere: antithombotics after intracerebral hemorrhage?.  66:162-163. 2006
  • Brainstem auditory evoked potential monitoring: when is change in wave V significant?.  65:1551-1555. 2005
  • Dysarthria and dysphagia from light chain amyloidosis..  65:1671. 2005
  • Long-term outcome of endovascular stenting for symptomatic basilar artery stenosis..  65:1340-1341. 2005
  • Age, dose, and environmental temperature are risk factors for topiramate-related hyperthermia..  65:1139-1140. 2005
  • Retinal microvascular signs and risk of stroke and stroke mortality..  65:1005-1009. 2005
  • Quantitative myasthenia gravis score: assessment of responsiveness and longitudinal validity..  64:1968-1970. 2005
  • Lower stroke-related mortality in counties with stroke centers: North Carolina Stroke Facilities Survey..  64:762-763. 2005
  • Family-based case-control study of cigarette smoking and Parkinson disease..  64:442-447. 2005
  • Osteoradionecrosis mimicking metastatic epidural spinal cord compression..  64:396-397. 2005
  • Age effects of coronary artery bypass graft on cognitive status change among elderly male twins..  63:2245-2249. 2004
  • Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis..  63:2039-2045. 2004
  • Impact of APOE in mild cognitive impairment..  63:1898-1901. 2004
  • Treating cognitive deficits in multiple sclerosis: are we there yet?.  63:1552-1553. 2004
  • Risk of ischemic stroke with tamoxifen treatment for breast cancer: a meta-analysis..  63:1230-1233. 2004
  • Krabbe disease: neurophysiologic studies and MRI correlations..  63:617-620. 2004
  • Susac syndrome with transient inverted vision..  63:591. 2004
  • Diet therapy for narcolepsy..  62:2300-2302. 2004
  • Apolipoprotein E controls the risk and age at onset of Parkinson disease..  62:2005-2009. 2004
  • VA Stroke Study: neurologist care is associated with increased testing but improved outcomes..  62:1914. 2004
  • Carotid arteriography: still golden after all these years?.  62:1246-1247. 2004
  • Aspirin: it's hard to beat..  62:1036-1037. 2004
  • Dementia: the leading predictor of death in a defined elderly population: the Cache County Study..  62:1156-1162. 2004
  • Mycophenolate mofetil for myasthenia gravis: an analysis of efficacy, safety, and tolerability..  61:1438-1440. 2003
  • Stroke location, characterization, severity, and outcome in mitral vs aortic valve endocarditis..  61:1341-1346. 2003
  • Hypoglossal neuropathy in hereditary neuropathy with liability to pressure palsy..  61:1154-1155. 2003
  • Occurrence of amyotrophic lateral sclerosis among Gulf War veterans..  61:742-749. 2003
  • Prognosis of patients with suspected primary CNS angiitis and negative brain biopsy..  61:831-833. 2003
  • VA Stroke Study: neurologist care is associated with increased testing but improved outcomes..  61:792-796. 2003
  • Clinical aspects of MuSK antibody positive seronegative MG..  60:1978-1980. 2003
  • Parkin-proven disease: common founders but divergent phenotypes..  60:1605-1610. 2003
  • Predict Resident Exam Performance (PREP) study..  60:1385-1387. 2003
  • Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease..  60:1189-1191. 2003
  • APOE genotype is a risk factor for neuropathy severity in diabetic patients..  60:1022-1024. 2003
  • Racial differences in survival post cerebral infarction among the elderly..  60:285-290. 2003
  • Regional brain chemical alterations in young children with autism spectrum disorder..  60:100-107. 2003